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Depressive Symptoms in Younger Women and Men With Acute
Myocardial Infarction: Insights From the VIRGO Study
Kim G. Smolderen, PhD; Kelly M. Strait, MS; Rachel P. Dreyer, PhD; Gail D’Onofrio, MD, MS; Shengfan Zhou, MS;
Judith H. Lichtman, PhD, MPH; Mary Geda, MSN; Hector Bueno, MD, PhD; John Beltrame, MD; Basmah Safdar, MD, MSc;
Harlan M. Krumholz, MD, SM; John A. Spertus, MD, MPH
Background-—Depression was recently recognized as a risk factor for adverse medical outcomes in patients with acute myocardial
infarction (AMI). The degree to which depression is present among younger patients with an AMI, the patient profile associated
with being a young AMI patient with depressive symptoms, and whether relevant sex differences exist are currently unknown.
Methods and Results-—The Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients (VIRGO) study enrolled
3572 patients with AMI (67.1% women; 2:1 ratio for women to men) between 2008 and 2012 (at 103 hospitals in the United
States, 24 in Spain, and 3 in Australia). Information about lifetime history of depression and depressive symptoms experienced
over the past 2 weeks (Patient Health Questionnaire; a cutoff score ≥10 was used for depression screening) was collected during
index AMI admission. Information on demographics, socioeconomic status, cardiovascular risk, AMI severity, perceived stress (14-
item Perceived Stress Scale), and health status (Seattle Angina Questionnaire, EuroQoL 5D) was obtained through interviews and
chart abstraction. Nearly half (48%) of the women reported a lifetime history of depression versus 1 in 4 in men (24%; P<0.0001).
At the time of admission for AMI, more women than men experienced depressive symptoms (39% versus 22%, P<0.0001; adjusted
odds ratio 1.64; 95% CI 1.36 to 1.98). Patients with more depressive symptoms had higher levels of stress and worse quality of life
(P<0.001). Depressive symptoms were more prevalent among patients with lower socioeconomic profiles (eg, lower education,
uninsured) and with more cardiovascular risk factors (eg, diabetes, smoking).
Conclusions-—A high rate of lifetime history of depression and depressive symptoms at the time of an AMI was observed among
younger women compared with men. Depressive symptoms affected those with more vulnerable socioeconomic and clinical
profiles. ( J Am Heart Assoc. 2015;4:e001424 doi: 10.1161/JAHA.114.001424)
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Y oung women aged <60 years who present with an acutemyocardial infarction (AMI) have an elevated risk of
mortality compared with men of that age group.1,2 A potential
mediator of their poor outcomes might be depressive
symptoms, which occur in 1 of every 3 patients with AMI3
and have been shown to be associated with detrimental long-
term outcomes.4–6 Although the nature and causality of the
mechanisms that might explain the association between
depressive symptoms and adverse prognosis in cardiac
disease have not been established, both biological (eg,
increased inflammation, inflammatory imbalance, increased
platelet reactivity) and behavioral (eg, smoking, obesity, poor
medication adherence) mechanisms have been proposed.7
Among depressed patients with AMI, some subpopulations
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may be particularly vulnerable to adverse outcomes.4,8 Prior
studies have suggested that demographic characteristics can
identify higher risk patients (eg, depressive symptoms are
present in 40% of women aged ≤60 years, whereas 1 in 5
men in that age group report having depressive symptoms).4,8
The need for further work to confirm and extend the existing
literature on the most vulnerable patients (eg, young women)4
is underscored by the latest scientific statement issued by the
American Heart Association, which elevated depression to the
status of an official risk factor in cardiac disease.6 A
significant gap remains in the knowledge about prevalence
and correlates of significant depressive symptoms among
young patients presenting with an AMI. Identifying subtypes
and characteristics of depression among young patients with
AMI can lay the foundation for developing novel targeted
treatments for depression in this group of patients.
The Variation in Recovery: Role of Gender on Outcomes of
Young AMI Patients (VIRGO) study was designed to examine
the risk factors and outcomes for young patients recovering
from an AMI.9 The goals of this study were (1) to evaluate the
degree to which depressive symptom burden (lifetime history
and depressive symptoms assessed during AMI admission) is
present among younger patients with AMI; (2) to examine the
demographic, socioeconomic, and clinical patient profiles
associated with being a young AMI patient and having
concomitant depressive symptoms; and (3) to examine the
association between sex and depressive symptoms in AMI
patients, independent of other risk factors. Being able to
address these goals could inform a more actionable approach
in risk-stratifying young men and women with AMI who are at
risk of experiencing depressive symptoms. We hypothesized
that female patients and those with more unfavorable
socioeconomic and clinical profiles would suffer from a higher
depression burden. Being able to address these aims would
allow us to identify key areas of focus for younger AMI
patients in designing plans for better prevention, identifica-
tion, and treatment of their depressive symptoms. In addition,
this study may also identify important characteristics that
differ by sex that might confound sex-based differences
between outcomes in younger patients with AMI.
Methods
Participants
Patients 18 to 55 years old with AMI were recruited into the
VIRGO study between August 21, 2008, and January 5, 2012,
from 103 hospitals in the United States, 24 in Spain, and 3 in
Australia using a 2:1 ratio of women to men for enrollment.
The methods of VIRGO have been described previously.9 In
brief, patients were eligible for the study if they had increased
cardiac biomarkers (ie, myocardial necrosis needed to be
present or at least 1 of the following markers needed to be
elevated: troponin I or T level >99th percentile of the upper
reference limit or creatine kinase level greater than twice the
upper reference limit with creatine kinase–MB activity level
>10% total) and at least 1 of the following conditions:
symptoms of ischemia or electrocardiographic changes
indicative of new ischemia (new ST-T changes, new or
presumably new left bundle branch block, or the development
of pathological Q waves). Only patients who presented
directly or who were transferred to the enrolling site within
the first 24 hours of presentation were eligible. Patients who
were incarcerated; who did not speak English or Spanish; who
were unable to provide informed consent or to be contacted
for follow-up; or who developed elevated cardiac markers as a
result of elective coronary revascularization, physical trauma,
or surgery were excluded. An overview of the actual reasons
for exclusion is provided in Table S1. Institutional review
board approval was obtained at each participating center, and
all patients provided informed consent for their study
participation.
Data Collection and Variables
Baseline hospitalization data were collected by medical chart
abstraction, and standardized in-person interviews were
administered by trained personnel during admission for AMI
or shortly thereafter (92% were performed in the hospital, 8%
were conducted within 3 days of discharge) (Table S2).
Depressive symptoms and health status data were collected
through the baseline interview.
Information about depression consisted of self-reported
lifetime history of depression collected at the time of the in-
person interview (“Have you ever in your life been told you
have depression or been treated for depression by a doctor or
other health care provider?” [yes or no]) and current
symptoms of depression assessed with the 9-item version
of the Patient Health Questionnaire (PHQ-9),10 a standardized
and validated instrument that has been used widely among
cardiac populations.4,11,12 The PHQ-9 quantifies the frequency
of depressive symptoms experienced in the past 2 weeks
based on the 9 criteria for a major depressive disorder
described in the Diagnostic and Statistical Manual of Mental
Disorders (fourth edition; DSM).13 Each item is answered
along a 4-point Likert scale with responses ranging from 0
(not at all) to 3 (nearly every day); a sum score between 0 and
27 points is derived by adding all responses. A PHQ-9 score
≥10 is commonly used as a screening criterion that has 88%
sensitivity and specificity to detect a major depressive
disorder.10 Depressive symptoms can further be classified
according to severity: none (scores 0 to 4), mild (scores 5 to
9), moderate (scores 10 to 14), moderately severe (15 to 19),
and severe (scores ≥20).
DOI: 10.1161/JAHA.114.001424 Journal of the American Heart Association 2
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Disease-specific health status was assessed with the
Seattle Angina Questionnaire (SAQ; physical limitations,
angina frequency, and quality of life domains were analyzed)
during the in-person interview at study enrollment. This
instrument asks patients to reflect on the health status that
they experienced in the 4 weeks prior to the assessment. This
widely used instrument has been validated and used in a
variety of coronary artery disease populations, including
AMI.14–18 Scores on each subscale range from 0 to 100, with
higher scores indicating better health status (ie, fewer
physical limitations, less angina, and better quality of life).
Generic health status at the time of patients’ AMI
admission was measured with the visual analog scale of the
standardized EuroQoL 5D instrument, which asks patients to
rate their current health on a scale from 0 (worst imaginable
health state) to 100 (best imaginable health state).19,20
Perceived stress levels that patients experienced over the
past month were assessed with the 14-item Perceived Stress
Scale (PSS).21 Items are answered along a 5-point Likert
scale, and scores on this instrument range from 0 to 56, with
higher scores referring to higher stress levels. The PSS has
been used previously in AMI populations.22
Sociodemographic factors considered in this study were
age and self-identified race (black, white, other [used as
reference category in our multivariable models]). For US
patients, an additional ethnicity variable was included (His-
panic versus not). Ethnicity is a different variable than race,
for example, patients can be Hispanic and black at the same
time. Race and ethnicity categories were captured using the
revised 1997 Office of Management and Budget definitions.23
Socioeconomic status was quantified by defining patients’
marital status, highest education, working status, health
insurance, and practice of avoiding health care because of
cost. All of this information was obtained through patient
interviews.
Medical history and clinical characteristics at AMI presen-
tation were abstracted for prior coronary symptoms. Coronary
disease included AMI, percutaneous coronary intervention or
coronary artery bypass grafting, congestive heart failure, and
angina. Other cardiac risk factors and comorbidities included
hypertension, current smoking (within past 30 days), obesity
(body mass index ≥30 kg/m2), prior stroke or transient
ischemic attack, peripheral arterial disease, renal dysfunction,
cancer, and chronic lung disease. Clinical severity of patients’
AMI presentations was assessed by Killip class, peak troponin
level, hemodynamic instability, final AMI diagnosis (ST-eleva-
tion AMI), and ejection fraction <40%. Cardiac symptoms
included typical versus atypical chest pain, back pain,
abdominal pain, nausea, other pain, shortness of breath,
fatigue, other cardiac symptoms, and other acute noncardiac
conditions at arrival (eg, stroke, acute kidney failure, sepsis),
a variable previously shown to be highly prognostic of
mortality.24 The number of cardiac symptoms experienced
by a patient were counted and recorded as a continuous
variable.
Finally, information about antidepressants at discharge and
newly prescribed antidepressants was abstracted from
patients’ medical records.
Study Sample
Of the 5585 patients meeting eligibility criteria, 3572 (64%)
were enrolled (2985 from the United States, 516 from Spain,
71 from Australia). The most common reasons for not
enrolling were refusal of informed consent and discharge
occurring prior to contact by the site study coordinator.
Because our primary objective was to look at the association
between depressive symptoms and patient characteristics in
women and men with an AMI, we restricted our depression
analyses to those who had PHQ-9 scores available. Depres-
sive symptom scores were uncommonly missing (≤4%; n=148)
without differences by sex (Table S3).
Statistical Analysis
To provide an overview of the patient characteristics for the
overall sample and by sex, frequencies and percentages were
used to summarize categorical variables, and medians,
means, standard deviations, and interquartile ranges were
reported to summarize continuous variables. Chi-square tests
for categorical variables and Wilcoxon rank-sum tests for
continuous variables were used to assess statistical signifi-
cance. A P value <0.05 was considered statistically signif-
icant. In addition, Cohen’s d effect sizes were calculated for
continuous variables for which mean and standard deviations
were provided.25
To describe the burden of depressive symptoms by sex, we
used the same descriptive approach: We summarized data on
the history of depression and current symptoms of depression
for the overall sample and by sex. Similarly, we described the
demographic, socioeconomic, and clinical profiles of patients
with AMI by sex and depression status.
Next, logistic regression models were used to assess the
independent relationship between sex and PHQ-9 scores
≥10. Sociodemographic, socioeconomic, medical history, and
health status variables were added sequentially to identify
the association of sex with depressive symptoms. The first
model included only sex; age and race were added next, and
the third step included socioeconomic variables (marital
status, education level, working status). The fourth step
added medical history information, including congestive heart
failure; prior AMI, percutaneous coronary intervention, or
coronary artery bypass grafting; prior stroke or transient
ischemic attack; peripheral arterial disease; history of
DOI: 10.1161/JAHA.114.001424 Journal of the American Heart Association 3
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diabetes; final AMI diagnosis; smoking in the past 30 days;
obesity; and chronic lung disease. In the final step, health
status information was added (SAQ subscales for angina
frequency, physical limitation, and quality of life). All analyses
were performed using SAS 9.3 (SAS Institute Inc). Figures
were created in R 2.15.1 (R Foundation for Statistical
Computing).
Results
Patient Characteristics for the Overall Population
and by Sex
There were 1175 men and 2397 women. Most characteristics
were similar between men and women (Table 1); however,
lower proportions of women were white and married. Women
presented with higher rates of diabetes and obesity but had
lower rates of hypercholesterolemia compared with men.
Women had also had higher rates of cancer and chronic lung
disease.
Mean SAQ physical limitation scores in patients who
recently had an AMI were lower in women compared with men
(Cohen’s d=0.33). About half of patients reported angina
symptoms in the 4 weeks leading up to their AMI, with lower
SAQ angina frequency and SAQ quality of life scores in
women compared with men (Cohen’s d=0.20 and 0.21,
respectively). The same pattern was observed for generic
health status (Cohen’s d=0.19). As compared with men,
perceived stress levels were highest among women (Cohen’s
d=0.40).
Depressive Symptoms by Sex
Significantly more women than men reported having had a
diagnosis of depression in the past (48% versus 24%;
P<0.0001). At the time of their AMI, more women than men
had significant depressive symptoms (PHQ-9 scores ≥10 in
39% of women versus 22% of men; P<0.0001). Of those who
had a history of depression, more than twice as many women
(26%) presented with PHQ-9 scores ≥10 as men (10%;
P<0.0001). Women also scored higher for the overall PHQ-9
(mean score of 97 versus 66 in men; Cohen’s d=0.46;
P<0.0001) (Table 2). Women were more likely to have PHQ-9
scores ≥10 in all 3 countries (Table S4).
Demographic, Socioeconomic, and Clinical
Profiles of Patients With AMI by Sex and by
Depression Status
Both women and men had different demographic and
socioeconomic patient profiles based on the level of their
PHQ-9 scores. Among patients who had PHQ-9 scores ≥10,
fewer married patients were noted, and fewer patients had a
full- or part-time job compared with women who had lower
depressive symptom scores. In addition, patients with PHQ-9
scores ≥10 had lower rates of completing high school or
higher levels of education and lower rates of health insurance
compared with those who had lower depressive symptom
scores, and more reported that they were avoiding getting
health care because of cost (Table 3).
With regards to their clinical profile, both women and men
with scores ≥10 on the PHQ-9 presented with higher rates of
cardiovascular comorbidity and risk factors (prior AMI,
percutaneous coronary intervention, or coronary artery
bypass grafting; congestive heart failure; hypertension; dia-
betes; hypercholesterolemia; smoking in the past 30 days;
prior stroke or transient ischemic attack; obesity; higher Killip
class), chronic lung disease, and more AMI symptoms
compared with those having lower depressive symptom
scores. Patients with PHQ-9 scores ≥10 experienced worse
health status and more stress compared with those who had
lower scores. Finally, antidepressants at discharge and newly
prescribed antidepressants were more common among
women and men with PHQ-9 scores ≥10 compared with
patients who had lower PHQ-9 scores. (Table 3).
Independent Association Between Sex and
Depressive Symptoms
Women had 2.28 greater odds of presenting with depressive
symptoms at the time of AMI compared with men (95% CI
1.94 to 2.69). After adjustment for demographic, socioeco-
nomic, clinical, and health status variables, the association
between female sex and significant depressive symptoms
persisted (odds ratio 1.64; 95% CI 1.36 to 1.98) (Table 4).
Other characteristics associated with having depressive
symptoms included history of cardiac disease, nonmarried
status, and being unemployed (Figure shows adjusted model
results, and Table S5 shows the fully adjusted model).
Sensitivity analyses were run to verify whether our findings
were different if each participating country’s data were
individually excluded to verify whether findings were robust
across these international settings, and results remained
essentially unchanged (data not shown).
Discussion
Although depression was recently recognized as a risk factor
for adverse medical outcomes in patients with AMI,6 many
basic questions remain with regard to the extent to which this
risk factor is prevalent among younger patients with AMI. We
found a much greater prevalence of prior depression and
concurrent depressive symptoms among young women with
DOI: 10.1161/JAHA.114.001424 Journal of the American Heart Association 4
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Table 1. Patient Characteristics for the Overall Sample and by Sex
Overall (N=3572, 100%) Men (n=1175, 32.9%) Women (n=2397, 67.1%)
n (%) n (%) n (%)
Sociodemographic characteristics
Age, range, y 18 to 55 23 to 55 18 to 55
Age, median (IQR), y 48 (44 to 52) 48 (43 to 52) 48 (44 to 52)
Race
White 2800 (78) 980 (84) 1820 (76)
Black 554 (16) 114 (10) 440 (18)
Other 212 (6) 79 (7) 133 (6)
Hispanic 269 (8) 92 (8) 177 (7)
Married 1827 (51) 678 (58) 1149 (48)
Socioeconomic characteristics
Education
Less than high school 185 (5) 47 (4) 138 (6)
High school 1459 (42) 489 (43) 970 (41)
More than high school 1860 (53) 612 (53) 1248 (53)
Work full or part time 2204 (62) 856 (73) 1348 (57)
Health insurance 2870 (80) 920 (78) 1950 (81)
Avoid getting health care because of cost 1070 (30) 333 (28) 737 (31)
Medical history
Prior AMI, PCI, or CABG 682 (19) 241 (21) 441 (18)
Angina 966 (27) 307 (26) 659 (28)
Congestive heart failure 141 (4) 24 (2) 117 (5)
Hypertension 2260 (63) 730 (62) 1530 (64)
Diabetes 1246 (35) 317 (27) 929 (39)
Hypercholesterolemia 3062 (86) 1080 (92) 1982 (83)
Smoked within past 30 days 2133 (60) 697 (59) 1436 (60)
Obesity (BMI ≥30 kg/m2) 1745 (49) 524 (45) 1221 (51)
Prior stroke/TIA 147 (4) 27 (2) 120 (5)
Peripheral arterial disease 80 (2) 23 (2) 57 (2)
Renal dysfunction 367 (10) 91 (8) 276 (12)
Cancer 119 (3) 23 (2) 96 (4)
Chronic lung disease 363 (10) 65 (6) 298 (12)
Health status
SAQ physical limitation score, mean (SD) 81 (25) 87 (21) 79 (27)
SAQ angina frequency score, mean (SD) 84 (20) 87 (18) 83 (21)
SAQ angina frequency categories
Daily (0 to 30) 96 (3) 16 (1) 80 (3)
Weekly (31 to 60) 566 (16) 158 (14) 408 (17)
Monthly (61 to 99) 1235 (35) 414 (35) 821 (34)
None (100) 1656 (46) 583 (50) 1073 (45)
SAQ quality of life score, mean (SD) 57 (24) 60 (22) 55 (25)
Continued
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Table 1. Continued
Overall (N=3572, 100%) Men (n=1175, 32.9%) Women (n=2397, 67.1%)
n (%) n (%) n (%)
EuroQoL 5D VAS, mean (SD) 64 (22) 67 (20) 63 (22)
PSS-14, mean (SD) 26 (10) 23 (10) 27 (10)
Clinical characteristics at AMI presentation
Killip class
I, no heart failure 3242 (92) 1083 (93) 2159 (91)
II, heart failure 110 (3) 26 (2) 84 (4)
III, pulmonary edema 26 (1) 4 (1) 22 (1)
IV, cardiogenic shock 21 (1) 5 (1) 16 (1)
Peak troponin level, median (IQR), ng/mL 6.9 (1.5 to 28.0) 9.6 (2.0 to 37.5) 5.8 (1.4 to 23.1)
Hemodynamic instability 309 (9) 97 (8) 212 (9)
Final AMI diagnosis: STEMI 1860 (52) 705 (60) 1155 (48)
Ejection fraction <40% 370 (11) 127 (11) 243 (11)
Experienced typical chest pain 2835 (79) 980 (83) 1855 (77)
Experienced atypical chest pain 634 (18) 164 (14) 470 (20)
Experienced back pain 514 (14) 118 (10) 396 (17)
Experienced abdominal pain 158 (4) 42 (4) 116 (5)
Experienced nausea 1477 (41) 409 (35) 1068 (45)
Experienced other type of pain 729 (20) 237 (20) 492 (21)
Experienced shortness of breath 1577 (44) 512 (44) 1065 (44)
Experienced fatigue 387 (11) 116 (10) 271 (11)
Experienced other symptoms 2284 (64) 739 (63) 1545 (64)
Had other acute noncardiac conditions at arrival 173 (5) 41 (4) 132 (6)
Number of symptoms, median (IQR) 3 (2 to 4) 3 (2 to 4) 3 (2 to 4)
AMI indicates acute myocardial infarction; BMI, body mass index; CABG, coronary artery bypass grafting; IQR, interquartile range; PCI, percutaneous coronary intervention; PSS-14, 14-item
Perceived Stress Scale; SAQ, Seattle Angina Questionnaire; STEMI, ST-elevation myocardial infarction; TIA, transient ischemic attack; VAS, visual analog scale.
Table 2. Descriptive Overview of Comorbid Depression Rates (History and Current Symptoms) for the Overall Sample and by Sex
Overall (N=3572, 100%) Men (n=1175, 32.9%) Women (n=2397, 67.1%) P Value
n (%) n (%) n (%)
History of depression 1421 (40) 280 (24) 1141 (48) <0.0001
PHQ-9 overall score, mean (SD)* 8 (6) 6 (6) 9 (7) <0.0001
PHQ-9 ≥10 1131 (33) 245 (22) 886 (39) <0.0001
PHQ-9 depression levels
No depression (score 0 to 4) 1333 (39) 577 (51) 756 (33) <0.0001
Mild depression (score 5 to 9) 960 (28) 310 (27) 650 (28)
Moderate depression (score 10 to 14) 552 (16) 141 (12) 411 (18)
Moderately severe depression (score 15 to 19) 364 (11) 68 (6) 296 (13)
Severe depression (score ≥20) 215 (6) 36 (3) 179 (8)
PHQ-9 ≥10 and history of depression 710 (21) 114 (10) 596 (26) <0.0001
PHQ-9 indicates 9-item Patient Heath Questionnaire.
*Only 3424 subjects had PHQ-9 overall scores (n=1132 for men, and n=2292 for women).
DOI: 10.1161/JAHA.114.001424 Journal of the American Heart Association 6
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Age, median (IQR), years 48 (43 to 52) 48 (44 to 51) 0.76 48 (44 to 52) 48 (44 to 52) 0.52
Race 0.61 0.06
White 736 (83) 209 (85) 1056 (75) 694 (79)
Black 87 (10) 23 (10) 261 (19) 153 (17)
Other 62 (7) 13 (5) 88 (6) 37 (4)
Hispanic 57 (6) 31 (13) 0.012 106 (8) 62 (7) 0.55
Married 536 (61) 118 (48) 0.0005 721 (51) 374 (42) <0.0001
Education 0.0013 0.0021
Less than high school 34 (4) 10 (4) 76 (5) 56 (6)
High school 342 (39) 126 (52) 532 (38) 392 (45)
More than high school 491 (57) 105 (44) 778 (56) 423 (49)
Work full or part time 685 (78) 144 (59) <0.0001 901 (64) 394 (45) <0.0001
Health insurance 724 (82) 171 (70) <0.0001 1176 (84) 689 (78) 0.0003
Avoid getting health care
because of cost
210 (24) 107 (44) <0.0001 349 (25) 361 (41) <0.0001
Medical history
Prior AMI, PCI, or CABG 166 (19) 68 (28) 0.0020 234 (17) 189 (21) 0.0051
Congestive heart failure 10 (1) 12 (5) 0.0002 57 (4) 58 (7) 0.0078
Hypertension 529 (60) 176 (72) 0.0005 836 (59) 624 (70) <0.0001
Diabetes 211 (24) 95 (39) <0.0001 492 (35) 394 (44) <0.0001
Hypercholesterolemia 805 (91) 235 (96) 0.0088 1131 (80) 759 (86) 0.0014
Smoked within past 30 days 493 (56) 176 (72) <0.0001 762 (54) 603 (68) <0.0001
Obesity (BMI ≥30 kg/m2) 384 (43) 121 (49) 0.0920 667 (48) 492 (56) 0.0002
Prior stroke/TIA 17 (2) 10 (4) 0.0497 65 (5) 48 (5) 0.39
Peripheral arterial disease 13 (1) 8 (3) 0.0670 31 (2) 25 (3) 0.36
Renal dysfunction 69 (8) 19 (8) 0.9945 148 (11) 114 (13) 0.08
Cancer 16 (2) 7 (3) 0.3009 54 (4) 37 (4) 0.69
Chronic lung disease 40 (5) 21 (9) 0.0128 116 (8) 170 (19) <0.0001
Health status
SAQ physical limitation score,
mean (SD)
91 (17) 74 (26) <0.0001 86 (22) 67 (31) <0.0001
SAQ quality of life score, mean (SD) 63 (21) 50 (22) <0.0001 61 (22) 45 (25) <0.0001
PSS-14, mean (SD) 21 (8) 32 (8) <0.0001 23 (8) 34 (8) <0.0001
Clinical characteristics at presentation
Killip class 0.0173 0.37
I, no heart failure 825 (94) 217 (89) 1273 (92) 793 (91)
II, heart failure 14 (2) 12 (5) 42 (3) 38 (4)
III, pulmonary edema 2 (1) 2 (1) 13 (1) 9 (1)
IV, cardiogenic shock 4 (1) 1 (1) 7 (1) 8 (1)
Continued
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AMI than among young men. Even after adjusting for
numerous sociodemographic, clinical, and disease severity
characteristics, young women with AMI had 60% greater odds
of having significant depressive symptoms than young men.
Moreover, at the time of their AMI, women with a history of
clinical depression were particularly vulnerable to experienc-
ing depressive symptoms compared with men with a history
of depression; up to a quarter of women with a history of
depression had current depressive symptoms versus 10% of
men with had a history of depression. Although there is
literature documenting sex differences in depression and
cardiovascular disease, the finding of higher prevalence of
depressive symptoms in young women with AMI compared
with men, in particular, has important implications.
Although preliminary studies have shed important insight
in this area, young women were often underrepresented in
prior studies of patients with AMI, and the studies are old or
missed detailed patient and depression information.1,4,5,8,26
The VIRGO study was able to accommodate these shortcom-











Final AMI diagnosis: STEMI 542 (61) 138 (56) 0.1764 697 (50) 408 (46) 0.1002
Experienced typical chest pain 745 (84) 195 (80) 0.1043 1098 (78) 677 (76) 0.3478
Experienced atypical chest pain 115 (13) 46 (19) 0.0212 260 (18) 186 (21) 0.1408
Experienced back pain 91 (10) 22 (9) 0.5542 231 (16) 154 (17) 0.5528
Experienced abdominal pain 26 (3) 15 (6) 0.0180 64 (5) 47 (5) 0.4136
Experienced nausea 298 (34) 94 (38) 0.1647 620 (44) 409 (46) 0.3329
Experienced other type of pain 165 (19) 59 (24) 0.0567 290 (21) 177 (20) 0.7074
Experienced shortness of breath 364 (41) 130 (53) 0.0008 565 (40) 452 (51) <0.0001
Experienced fatigue 80 (9) 33 (13) 0.0397 141 (10) 117 (13) 0.0191
Experienced other symptoms 544 (61) 164 (67) 0.1084 904 (64) 575 (65) 0.7691
Had other acute noncardiac conditions
at arrival
23 (3) 17 (7) 0.0012 65 (5) 55 (6) 0.1099
Number of symptoms, median (IQR) 3 (2, 4) 3 (2, 4) 0.0004 3 (2, 4) 3 (2, 4) 0.0035
Depression treatment information during AMI admission
Antidepressant use at discharge 60 (7) 47 (19) <0.0001 217 (15) 274 (31) <0.0001
Newly prescribed antidepressants 15 (2) 6 (3) 0.29 25 (2) 44 (7) <0.0001
AMI indicates acute myocardial infarction; BMI, body mass index; CABG, coronary artery bypass grafting; IQR, interquartile range; PCI, percutaneous coronary intervention; PHQ, 9-item
Patient Health Questionnaire; PSS-14, 14-item Perceived Stress Scale; SAQ, Seattle Angina Questionnaire; STEMI, ST-elevation myocardial infarction; TIA, transient ischemic attack.
Table 4. Sequential Logistic Regression Results for the Relationship Between Female Sex and PHQ-9 Scores ≥10
Model
Number
Odds Ratio for Female
Sex (95% CI) Covariates Included in the Model
1 2.28 (1.94 to 2.69) Sex
2 2.30 (1.95 to 2.71) Sex, age, race
3 1.99 (1.68 to 2.36) Sex, age, race, marital status, education level, employment status
4 1.86 (1.56 to 2.22) Sex, age, race, marital status, education level, employment status, congestive heart failure, prior AMI/PCI/
CABG, prior stroke/TIA, peripheral arterial disease, history of diabetes, STEMI, smoking in past 30 days,
obesity status, chronic lung disease
5 1.64 (1.36 to 1.98) Sex, age, race, marital status, education level, employment status, congestive heart failure, prior AMI/PCI/
CABG, prior stroke/TIA, peripheral arterial disease, history of diabetes, STEMI, smoking in past 30 days,
obesity status, chronic lung disease, SAQ physical limitation, SAQ quality of life
AMI indicates acute myocardial infarction; CABG, coronary artery bypass grafting; PCI, percutaneous coronary intervention; SAQ, Seattle Angina Questionnaire; STEMI, ST-elevation
myocardial infarction; TIA, transient ischemic attack.
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depressive symptomatology. This understanding may be
helpful in future studies examining depression as a potential
explanatory mechanism for the adverse outcomes of younger
women recovering from an AMI. Importantly, a novel finding of
this study, the long lifetime history of depression with greater
depressive symptoms at the time of an AMI, suggests
inadequate treatment of known depression and warrants
further investigation into biological (eg, genetic, inflammation)
and psychosocial triggers that may underlie this unusually
high depression burden among young women. An alternative
explanation for the increased depressive symptom burden
may be that women with depression suffered from a high
comorbidity burden (eg, diabetes, obesity, chronic lung
disease). This burden may predispose women to experiencing
more depressive symptoms, although adjustment for these
factors did not affect the association between female sex and
having increased depressive symptoms in the current study.
Regardless of cause, having depressive symptoms that
interfere with daily functioning warrants appropriate treatment
in its own right. Experiencing depressive symptoms and also
having coronary disease may further complicate recovery
because both limit daily function and may negatively affect
patients’ rehabilitation.27 Another reason why depressive
symptoms in cardiac patients deserve special consideration
is that prevalence seems to be disproportionately high, and
this remains the case over the years. Both in women and men
with AMI who were aged 18 to 55 years, 3 times as many
patients had PHQ-9 scores ≥10 compared with the general
population (depression rates among men and women aged 40
to 59 years are 7% and 12%, respectively, as measured in the
US National Health and Nutrition Examination Survey study28
with the PHQ-9 ≥10 criterion).29 The prevalence estimates for
depression in the younger patients with AMI in this study are
also fairly consistent with those obtained from data collected 5
to 8 years ago. In the PREMIER study, 40% of women aged
<60 years had PHQ-9 scores ≥10 and 22% of younger men had
increased PHQ-9 scores, suggesting that little progress has
been made to effectively address this burden.4 Despite several
initiatives to better recognize and treat depression in coronary
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Figure. Forest plot of the fully adjusted logistic regression model to assess the relationship between
female sex and scores ≥10 on the 9-item Patient Health Questionnaire. Odds ratios and 95% CIs are
depicted. CABG indicates coronary artery bypass grafting; HF, heart failure; MI, myocardial infarction; PAD,
peripheral arterial disease; PCI, percutaneous coronary intervention; SAQ, Seattle Angina Questionnaire;
STEMI, ST-elevation myocardial infarction; TIA, transient ischemic attack.
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constitutes a major risk for future adverse AMI prognosis,5,6
prevalence rates for depression remain exceedingly high.
A study finding that requires further reflection is that
nearly half of younger women (≤55 years) had a diagnosis of
depression at some point in their lives versus 24% of
younger men (≤55 years); however, half of those who had
PHQ-9 scores ≥10 around the time of their AMI did not have
a history of depression. The same pattern was observed for
younger men, except that their depression history rates
were half those of younger women. Although our cross-
sectional design and the self-report of lifetime history of
depression may limit us in finding an actual explanation for
our findings, several hypotheses can be formulated and will
need further testing in the future. Patients’ new depressive
symptoms may have been specifically associated with the
impending AMI or perhaps, in a substantial amount of
patients, depressive symptoms went unnoticed and
untreated in the past. It is known that women who present
with chest pain at the emergency department without
evidence of coronary disease but with cardiac risk factors
already seem vulnerable to experiencing high rates of
depressive symptoms.32 The tenacity of women’s depressive
symptom burden in cardiac disease requires more extensive
evaluation to understand whether patients’ symptoms of
depression were correctly diagnosed or adequately treated
in the past, whether other psychological comorbidities are
present that need to be addressed along with the depres-
sion, whether the depression had been completely in
remission in the past, or whether women tend to experience
more treatment-resistant symptoms of depression. Another
potential explanation may be that the very high rate of
depressive symptoms is, in part, secondary to the experi-
ence of the AMI. Regardless, depression seems to be a
recurrent concern over the course of life in a large group of
patients with AMI.
Increased awareness and intensified treatment for coro-
nary patients’ depressive symptoms can be very beneficial.
Similarly, the high stress scores noted in both younger men
and women who had PHQ-9 scores ≥10 are modifiable and
important treatment targets that are also associated with
adverse cardiac disease outcomes.22,33 Recently, several
intervention studies have been shown to be helpful in
reducing depressive symptoms and stress, improving
patients’ quality of life, and rendering promising results with
regard to patients’ cardiovascular prognosis.30,31,34 These
intervention studies combined elements of cognitive–behav-
ioral and problem-solving therapies, stress-reduction tech-
niques, and stepped depression and collaborative care
programs. The profile information provided in this study could
be used to design a tailored prevention or intervention
program incorporating these techniques. Through existing
community programs that have already identified younger
persons with vulnerable socioeconomic positions (eg, not
having a partner, being unemployed, having less education),
one could focus on preventive strategies and improving
recognition of depression and on aggressive management of
cardiovascular risk factors. The current study highlights that
in such programs, potentially lower literacy levels and other
socioeconomic barriers need to be considered because
younger patients with depressive symptoms presented with
very unfavorable socioeconomic profiles. Having this specific
information about this younger population facing depression
is important for designing targeted depression-intervention
programs. The correlates of depression seem to be unique to
the challenges of the phase of life that each individual faces.
As a comparison, at older ages, female sex is still a predictor
of having depression, but other factors like functional and
cognitive decline and social isolation seem to be more
prominent characteristics of persons dealing with depressive
symptoms.35 Providing access to tailor-made programs that
address the risk factors unique to a younger population like
that studied in VIRGO and using some of the elements studied
in recent depression-intervention studies could offer a way to
attenuate the high coronary and psychiatric risk of these
younger persons.
This study should be interpreted within the context of
several potential limitations. It is impossible to discern
whether the depressive symptoms noted in this observational
study were a cause or an effect of patients’ AMI, although the
PHQ-9 inquires about symptoms over the past 2 weeks (prior
to the AMI), and women’s increased risk of depression was
independent of AMI severity, comorbid conditions, cardiovas-
cular risk factors, and health status. Regardless of the
direction of the relationship, it is important to note that
depressive symptoms can be treated successfully. There is a
potential concern about recall bias associated with the self-
report data on lifetime history of depression; however,
previous research has indicated that this way of measuring
lifetime history of depression may result in underreporting of
lifetime history of depression rates; if anything, the estimates
of the depressive symptom burden in our AMI population may
reflect underrepresentation.36,37 Other limitations of this
study include the potential for residual confounding, the lack
of a diagnostic interview for a DSM diagnosis of current
depression,13 and the inability to look at potential mecha-
nisms as to why women incurred the highest risk of
experiencing depressive symptoms prior to their AMI.
Hormonal differences, combining several life roles, being a
single parent, and working in lower paid jobs are just a few
potential reasons identified in the past that could help explain
the observed sex differences in depressive symptoms.38
Future studies will be needed to replicate our findings and to
better define the mechanisms of young patients’ depressive
symptoms.
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In summary, the burden of depressive symptoms is very
high among young patients with an AMI, particularly among
younger women. Regardless of sex, depressive symptoms
seem to primarily strike patients with lower socioeconomic
status and are accompanied by high levels of stress and
decreased functional status. This information will be useful to
target future prevention and intervention programs that can
help address depression as an important cardiac risk factor in
this vulnerable group of patients.
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Table S1 – Reasons For Not Enrolling Into the Study. Categories are not mutually exclusive, as 
patients could have selected more than one reason for not participating into the study.* 
 
Reason N (%) 
Discharged prior to being contacted by site study coordinator 551 (29) 
Refused informed consent 949 (50) 
Other reason 392 (21) 
Spanish speaking and translator not available 11 (<1) 
*202 patients had not had a recorded reason for not enrolling. 
 
 
Table S2 – Overview of Descriptives for Time Windows Around Patient Interviews. 
 
Baseline Interview Window (N=3,572) 
 N (%) 
Interviewed in-hospital 3,280 (92%) 













Missing PHQ-9 score 148 (4%) 43 (4%) 105 (4%) 
 
  
Table S4 –Depressive Symptoms (PHQ-9≥10) by Country and by Gender. 
 
 Overall Men Women 
United States 34% 22% 39% 
Spain 31% 17% 38% 




Table S5 - Fully Adjusted Logistic Regression Model Results Evaluating the Relationship 
Between Female Gender and PHQ-9 Scores ≥ 10. Odds Ratios [OR] and 95% Confidence Intervals 
[95% CI] are depicted. Abbreviations: PHQ-9, Patient Health Questionnaire-9 item version; MI, 
myocardial infarction; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft; 
HF, heart failure; TIA, transient ischemic attack; PAD, peripheral arterial disease; SAQ, Seattle 
Angina Questionnaire; STEMI, ST-elevation myocardial infarction.  
Variable Odds Ratio 95% CI P-Value 
Socio-Demographic 
Characteristics    
Female gender 1.67 1.38-2.01 <0.0001 
Age (per 1 unit 
increase) 
1.00 0.99-1.01 0.9866 
White race 1.39 0.95-2.04 0.0009 
Black race 0.87 0.57-1.34 0.0445 
Socio-Economic 
Characteristics 
   
Not married 1.23 1.04-1.46 0.0177 
Less than high school 
education 
1.16 0.81 – 1.67 0.5796 
Completed some high 
school education 
1.10 0.93-1.32 0.8336 
Not Employed 1.46 1.22-1.75 <0.0001 
Medical History    
Prior MI/PCI/CABG 0.78 0.63-0.98 0.0305 
History of HF 0.88 0.57-1.35 0.5474 
History of diabetes 1.34 1.12-1.61 0.0013 
Smoked within past 30 
days 
1.67 1.40-2.00 <0.0001 
Obese 1.12 0.94-1.33 0.2043 
Prior stroke/TIA 0.91 0.59-1.38 0.6453 
History of PAD 0.78 0.46-1.35 0.3775 
History of lung disease 1.44 1.10-1.89 0.0076 
Health Status    
SAQ physical 
limitations (per 1 unit 
increase) 
0.98 0.97-0.99 <0.0001 
SAQ quality of life 
(per 1 unit increase) 
0.98 0.97-0.98 <0.0001 
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